Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880267 · ClinicalTrials.gov registry record · NA
Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System
A NA study, sponsored by DexCom.
- Completed
- Registry status
- NA
- Development phase
- 304
- Enrollment target
NCT02880267: Completed NA study, sponsored by DexCom.
NCT02880267 is a NA study that has completed, run by DexCom. The registered enrollment target is 304 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02880267, a NA study, has completed, sponsored by DexCom.
- COMPLETED
- Registry status
- NA
- Development phase
- 304 participants
- Enrollment target
Study Summary
Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring (CGM) System
Interventions
- DEVICE CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 304 participants |
| Start Date | 2016-05 |
| Est. Completion | 2017-09 |
| Phase | NA |
What the finished NCT02880267 record still lists
NCT02880267 is an interventional study that assigns participants to a tested intervention. The registered 304 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (78% lower).
The record links to 0 conditions, and to 1 intervention - of which CGM is the first listed.
NCT02880267 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02880267 about?
NCT02880267 is a clinical study titled "Effectiveness and Safety of the Dexcom™ G6 Continuous Glucose Monitoring System". Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring (CGM) System
What is the current status of trial NCT02880267?
This trial is currently completed. It is a NA study. The enrollment target is 304 participants. The study started on 2016-05. Estimated completion is 2017-09.
What interventions are being tested in trial NCT02880267?
The interventions under investigation include: CGM (DEVICE).
Who is sponsoring clinical trial NCT02880267?
This trial is sponsored by DexCom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02880267's enrollment target sits among peer trials
304 327th of 2000 higher than 1,672 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04750616 · 304 participants · Phase 2
NAD+ Augmentation in Cardiac Surgery Associated Myocardial Injury Trial
- NCT04994717 · 304 participants · Phase 3
Study Comparing Blinatumomab Alternating With Low-intensity Chemotherapy Versus Standard of Care Chemotherapy for Older Adults With Newly Diagnosed Philadelphia-negative B-cell Precursor Acute Lymphoblastic Leukemia
- NCT06036147 · 304 participants · NA
Concussion Health Improvement Program
- NCT06096844 · 304 participants · Phase 3
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia